Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
Recruiting · NCT07214688 · Registry updated 2026-03-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies | Allogeneic Stem Cell Transplant Recipient | Recruiting | Phase 2 | 2026-03-23 | NCT07214688 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hackensack Meridian Health | 52 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| John Theurer Cancer Center at Hackensack University Medical Center | Hackensack | United States | 37 |
| John Theurer Cancer Center at Jersey Shore University Medical Center | Neptune City | United States | 2 |
| Lombardi Comprehensive Cancer Center at Georgetown University Medical Center | Washington D.C. | United States | 3 |